HRHarsha Ravishankar

Harsha Ravishankar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Harsha Ravishankar has a total of 66 co-authors. Here are the top co-authors by number of shared publications:

  • Jung-Eun Park

    Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA

    4 shared publications
  • Kyung S. Lee

    Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA

    4 shared publications
  • Yan Zeng

    Cancer Innovation Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, USA

    4 shared publications
  • Bonsu Ku

    Orphan Disease Therapeutic Target Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea

    3 shared publications
  • Jong Il Ahn

    Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA

    3 shared publications
  • Klára Kirsch

    Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA

    3 shared publications

Latest Publications

  • Open Access

    Cep57 organizes pericentriolar material through dual architectural modules and prevents human mosaic variegated aneuploidy

    by Jong Il Ahn, Jung-Eun Park, Hye-Yeoung Yun, Yan Zeng, Klara Kirsch, Vipin Kumar, Bonsu Ku, Arlene Bartolome, Harsha Ravishankar, Ruchi Bhardwaj, et al.

    Mosaic variegated aneuploidy (MVA) is a developmental disorder associated with chromosome segregation defects. Mutations in the centrosomal protein Cep57 cause MVA2 syndrome, yet the molecular basis of Cep57 function has remained unclear. Here, using MINFLUX nanoscopy, structural biology, biochemical approaches, and analyses of patient-derived cells, we show how Cep57 organizes the inner pericentriolar material (PCM) to support centriole biogenesis. We show that Cep57 acts as a molecular bridge between centriolar microtubules and the PCM through two architecturally distinct interactions. Its oligomeric C-terminus anchors to centriolar microtubules, whereas its dimeric N-terminus engages Cep63 through a conserved bundle-like interaction, thereby linking the Cep63–Cep152 platform to the centriole and recruiting Plk4 and other components required for procentriole formation. Analysis of primary T lymphocytes from MVA2 patients carrying the Cep63-binding-defective CEP57 ∆exon 3 mutation reveals a predominant centriole-duplication defect accompanied by minor centriole amplification, likely resulting from disorganized PCM-induced premature centriole disengagement. Our findings show Cep57 as a central architectural organizer that couples centriolar microtubules to the molecular machinery driving centriole biogenesis, providing a mechanistic framework for understanding centrosome dysfunction and aneuploidy-associated diseases.

  • Open Access

    Specific inhibition of an anticancer target, polo-like kinase 1, by allosterically dismantling its mechanism of substrate recognition

    by Jung-Eun Park, Klara Kirsch, Hobin Lee, Paola Oliva, Jong Il Ahn, Harsha Ravishankar, Yan Zeng, Stephen D. Fox, Samuel A. Kirby, Pooja Badhwar, et al.

    Polo-like kinase 1 (Plk1) is considered an attractive target for anticancer therapy. Over the years, studies on the noncatalytic polo-box domain (PBD) of Plk1 have raised the expectation of generating highly specific protein–protein interaction inhibitors. However, the molecular nature of the canonical PBD-dependent interaction, which requires extensive water network–mediated interactions with its phospholigands, has hampered efforts to identify small molecules suitable for Plk1 PBD drug discovery. Here, we report the identification of the first allosteric inhibitor of Plk1 PBD, called Allopole, a prodrug that can disrupt intracellular interactions between PBD and its cognate phospholigands, delocalize Plk1 from centrosomes and kinetochores, and induce mitotic block and cancer cell killing. At the structural level, its unmasked active form, Allopole-A, bound to a deep Trp-Phe-lined pocket occluded by a latch-like loop, whose adjoining region was required for securely retaining a ligand anchored to the phospho-binding cleft. Allopole-A binding completely dislodged the L2 loop, an event that appeared sufficient to trigger the dissociation of a phospholigand and inhibit PBD-dependent Plk1 function during mitosis. Given Allopole’s high specificity and antiproliferative potency, this study is expected to open an unexplored avenue for developing Plk1 PBD-specific anticancer therapeutic agents.


  • Open Access

    Author Correction: Architectural basis for cylindrical self-assembly governing Plk4-mediated centriole duplication in human cells

    by Jong Il Ahn, Liang Zhang, Harsha Ravishankar, Lixin Fan, Klara Kirsch, Yan Zeng, Lingjun Meng, Jung-Eun Park, Hye-Yeoung Yun, Rodolfo Ghirlando, et al.

  • Open Access

    Architectural basis for cylindrical self-assembly governing Plk4-mediated centriole duplication in human cells

    by Jong Il Ahn, Liang Zhang, Harsha Ravishankar, Lixin Fan, Klara Kirsch, Yan Zeng, Lingjun Meng, Jung-Eun Park, Hye-Yeoung Yun, Rodolfo Ghirlando, et al.

    Proper organization of intracellular assemblies is fundamental for efficient promotion of biochemical processes and optimal assembly functionality. Although advances in imaging technologies have shed light on how the centrosome is organized, how its constituent proteins are coherently architected to elicit downstream events remains poorly understood. Using multidisciplinary approaches, we showed that two long coiled-coil proteins, Cep63 and Cep152, form a heterotetrameric building block that undergoes a stepwise formation into higher molecular weight complexes, ultimately generating a cylindrical architecture around a centriole. Mutants defective in Cep63•Cep152 heterotetramer formation displayed crippled pericentriolar Cep152 organization, polo-like kinase 4 (Plk4) relocalization to the procentriole assembly site, and Plk4-mediated centriole duplication. Given that the organization of pericentriolar materials (PCM) is evolutionarily conserved, this work could serve as a model for investigating the structure and function of PCM in other species, while offering a new direction in probing the organizational defects of PCM-related human diseases.


  • Open Access

    Tracking the ATP-binding response in adenylate kinase in real time

    by Fredrik Orädd, Harsha Ravishankar, Jack Goodman, Per Rogne, Lars Backman, Annette Duelli, Martin Nors Pedersen, Matteo Levantino, Michael Wulff, Magnus Wolf-Watz, et al.

    Time-resolved x-ray solution scattering identifies cooperative structural dynamics in the adenylate kinase enzymatic reaction.


  • Open Access

    Tracking Ca 2+ ATPase intermediates in real time by x-ray solution scattering

    by Harsha Ravishankar, Martin Nors Pedersen, Mattias Eklund, Aljona Sitsel, Chenge Li, Annette Duelli, Matteo Levantino, Michael Wulff, Andreas Barth, Claus Olesen, et al.

    Sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) transporters regulate calcium signaling by active calcium ion reuptake to internal stores. Structural transitions associated with transport have been characterized by x-ray crystallography, but critical intermediates involved in the accessibility switch across the membrane are missing. We combined time-resolved x-ray solution scattering (TR-XSS) experiments and molecular dynamics (MD) simulations for real-time tracking of concerted SERCA reaction cycle dynamics in the native membrane. The equilibrium [Ca2]E1 state before laser activation differed in the domain arrangement compared with crystal structures, and following laser-induced release of caged ATP, a 1.5-ms intermediate was formed that showed closure of the cytoplasmic domains typical of E1 states with bound Ca2+ and ATP. A subsequent 13-ms transient state showed a previously unresolved actuator (A) domain arrangement that exposed the ADP-binding site after phosphorylation. Hence, the obtained TR-XSS models determine the relative timing of so-far elusive domain rearrangements in a native environment.


  • Genetic association analysis of KCNQ3 and juvenile myoclonic epilepsy in a South Indian population

    by J. Vijai, A. Kapoor, H. M. Ravishankar, P. J. Cherian, A. S. Girija, B. Rajendran, G. Rangan, S. Jayalakshmi, S. Mohandas, K. Radhakrishnan, et al.

    Juvenile myoclonic epilepsy (JME) is a common subtype of idiopathic generalized epilepsy that shows a complex pattern of inheritance. We have tested the association between JME phenotype and an intragenic marker in KCNQ3 by using the transmission disequilibrium test in 119 probands and their parents. Mutations in KCNQ3 are known to cause benign familial neonatal convulsions and are involved in the physiologically important M current in neurons. Our results provide suggestive evidence of allelic association between JME and KCNQ3 (P-value=0.008) and raise an interesting possibility of a genetic contribution to JME, viz., of a gene that causes a monogenic form of human epilepsy.